Exact Sciences Corp logo

Exact Sciences Corp

NAS:EXAS (USA)  
4
$ 66.85 -2.68 (-3.85%) 11:09 PM EST
P/E:
At Loss
P/B:
3.95
Market Cap:
$ 12.08B
Enterprise V:
$ 14.35B
Volume:
2.35M
Avg Vol (2M):
1.39M
Also Trade In:
Volume:
2.35M
Market Cap $:
12.08B
PE Ratio:
At Loss
Avg Vol (2M):
1.39M
Enterprise Value $:
14.35B
PB Ratio:
3.95

Business Description

Exact Sciences Corp logo
Exact Sciences Corp
NAICS : 621511 SIC : 8731
ISIN : US30063P1057
Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of the earliest entrants in multi-cancer liquid biopsy cancer screening.
Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset 0.48
Debt-to-Equity 0.84
Debt-to-EBITDA -11.8
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.82
Distress
Grey
Safe
Beneish M-Score -2.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 8.25
9-Day RSI 17.29
14-Day RSI 24.21
6-1 Month Momentum % 27.57
12-1 Month Momentum % 138.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.41
Quick Ratio 2.14
Cash Ratio 1.59
Days Inventory 72.28
Days Sales Outstanding 28.41
Days Payable 46.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.4
Shareholder Yield % -0.63

Financials (Next Earnings Date:2023-11-03 Est.)

EXAS's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EXAS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Exact Sciences Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,300.611
EPS (TTM) ($) -2.43
Beta 1.02
Volatility % 56.24
14-Day RSI 24.21
14-Day ATR ($) 2.505977
20-Day SMA ($) 79.0665
12-1 Month Momentum % 138.31
52-Week Range ($) 29.27 - 100.77
Shares Outstanding (Mil) 180.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Exact Sciences Corp Filings

Filing Date Document Date Form
No Filing Data

Exact Sciences Corp Stock Events

Event Date Price($)
No Event Data

Exact Sciences Corp Frequently Asked Questions

What is Exact Sciences Corp(EXAS)'s stock price today?
The current price of EXAS is $66.85. The 52 week high of EXAS is $100.77 and 52 week low is $29.27.
When is next earnings date of Exact Sciences Corp(EXAS)?
The next earnings date of Exact Sciences Corp(EXAS) is 2023-11-03 Est..
Does Exact Sciences Corp(EXAS) pay dividends? If so, how much?
Exact Sciences Corp(EXAS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1